COVID-19 vaccine reactogenicity in persons with multiple sclerosis

被引:0
|
作者
Briggs, F. [1 ]
Mateen, F. [2 ]
Schmidt, H. [3 ]
Currie, K. [4 ]
Siefers, H. [5 ]
Crouthamel, S. [6 ]
Bebo, B. [7 ]
Fiol, J. [8 ]
Racke, M. [9 ]
O'Connor, K. [10 ,11 ]
Kolaczkowski, L. [12 ]
Klein, P. [13 ]
McBurney, R. [3 ]
Loud, S. [3 ]
机构
[1] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
[2] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[3] Accelerated Cure Project MS, Waltham, MA USA
[4] Currie Consultancy Agcy LLC, Eastover, SC USA
[5] Int AIDS Vaccine Initiat, Frederick, MD USA
[6] Mammoth Hosp, Mammoth Lakes, CA USA
[7] Natl Multiple Sclerosis Soc USA, Portland, OR USA
[8] Natl Multiple Sclerosis Soc USA, Bel Air, CA USA
[9] Quest Diagnost, Med Affairs, Secaucus, NJ USA
[10] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA
[11] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA
[12] iConquerMS, Beavercreek, OH USA
[13] iConquerMS, Waltham, MA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P944
引用
收藏
页码:768 / 769
页数:2
相关论文
共 50 条
  • [41] COVID-19 vaccination patterns and outcomes among persons with multiple sclerosis in the FlywheelMS cohort
    Geiger, C.
    Sheinson, D.
    Boudreau, D.
    Mace, K.
    Hanson, G.
    Belendiuk, K.
    Bajaj, P.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 872 - 872
  • [42] Multiple Sklerose und COVID-19Multiple Sclerosis and COVID-19
    Michael Guger
    Gerhard Traxler
    psychopraxis. neuropraxis, 2021, 24 (2) : 98 - 101
  • [43] COVID-19 and multiple sclerosis: a thematic analysis of the unique experiences of people with multiple sclerosis during the COVID-19 pandemic
    Simcock-Davies, A.
    Da Silva, A.
    Craig, E. M.
    Middleton, R. M.
    Nicholas, R.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 686 - 687
  • [44] EVALUATION OF MRNA COVID-19 VACCINE REACTOGENICITY AND SAFETY IN MYASTHENIA GRAVIS PATIENTS.
    Gamez, Josep
    Gamez, Alejandro
    Carmona, Francesc
    MUSCLE & NERVE, 2022, 65 : S20 - S20
  • [45] Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis
    Francisco Ramos, Alberto San
    Sanchez, Carolina Liu
    Bovill Rose, Tatiana
    Smith, David
    Thorn, Natasha
    Galiza, Eva
    Miah, Thahmena
    Pearce, Jennifer
    Hultin, Cecilia
    Cosgrove, Catherine
    Hsia, Yingfen
    Heath, Paul T.
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 266 - 282
  • [46] MULTIPLE SCLEROSIS AND THE PSYCHOLOGICAL IMPACT OF COVID-19
    Morris-Bankole, H.
    Ho, A.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 68 - 68
  • [47] Multiple sclerosis patients and the COVID-19 pandemic
    Canzonieri, A. M.
    de Sousa, D.
    de Almeida, B.
    Soares, J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 737 - 738
  • [48] Response of the multiple sclerosis community to COVID-19
    Ciccarelli, Olga
    Cohen, Jeffrey A.
    Thompson, Alan
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (10) : 1134 - 1136
  • [49] COVID-19 in multiple sclerosis: The Dutch experience
    Loonstra, Floor C.
    Hoitsma, Elske
    van Kempen, Zoe L. E.
    Killestein, Joep
    Mostert, Jop P.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (10) : 1256 - 1260
  • [50] Multiple sclerosis and COVID-19: The Swedish experience
    Landtblom, Anne-Marie
    Berntsson, Shala G.
    Bostrom, Inger
    Iacobaeus, Ellen
    ACTA NEUROLOGICA SCANDINAVICA, 2021, 144 (03): : 229 - 235